CURD, JOHN G.,KROLL, STEWART,MATTEUCCI, MARK,HART, CHARLES P.,DUAN, JIAN-XIN
申请号：
EP09822657
公开号：
EP2350664A4
申请日:
2009.10.21
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
Cancer can be treated by administration of a hypoxia-activated prodrug, such as TH-302, alone or in combination with other anticancer agents and/or radiation therapy. In combination therapy, the hypoxia-activated prodrug and another anti-cancer agent or radiation therapy may be administered within the same 24-hour period, and administration of the hypoxia-activated prodrug may be completed prior to beginning administration of the other anticancer agent or radiation therapy.
